Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with...
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation
About this item
Full title
Author / Creator
Ocio, Enrique M. , Perrot, Aurore , Bories, Pierre , San-Miguel, Jesus F. , Blau, Igor W. , Karlin, Lionel , Martinez-Lopez, Joaquin , Wang, Song-Yau , Bringhen, Sara , Marcatti, Magda , Mateos, María-Victoria , Rodriguez-Otero, Paula , Oliva, Stefania , Nogai, Axel , Le Roux, Nadia , Dong, Liyan , Macé, Sandrine , Gassiot, Matthieu , Fitzmaurice, Thomas , Oprea, Corina and Moreau, Philippe
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Patients with newly diagnosed multiple myeloma (NDMM) ineligible for autologous stem cell transplantation (ASCT) have lower survival rates and may benefit from frontline regimens that include novel agents. This Phase 1b study (NCT02513186) evaluated preliminary efficacy, safety, and pharmacokinetics (PK) of isatuximab, an anti-CD38 monoclonal antib...
Alternative Titles
Full title
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation
Authors, Artists and Contributors
Author / Creator
Perrot, Aurore
Bories, Pierre
San-Miguel, Jesus F.
Blau, Igor W.
Karlin, Lionel
Martinez-Lopez, Joaquin
Wang, Song-Yau
Bringhen, Sara
Marcatti, Magda
Mateos, María-Victoria
Rodriguez-Otero, Paula
Oliva, Stefania
Nogai, Axel
Le Roux, Nadia
Dong, Liyan
Macé, Sandrine
Gassiot, Matthieu
Fitzmaurice, Thomas
Oprea, Corina
Moreau, Philippe
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10264885
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10264885
Other Identifiers
ISSN
0887-6924,1476-5551
E-ISSN
1476-5551
DOI
10.1038/s41375-023-01936-7
